Andrew Yule & Co (ANDREWYU)
TurnaroundFairStock Score: 6/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹31.7 |
| Market Cap | ₹1,556.4 Cr |
| P/E Ratio | 98.46 |
| ROCE | -6.83% |
| ROE | -5.78% |
| Dividend Yield | 0% |
| Profit Growth | 38.07% |
| Debt/Equity | 0.37 |
| Sales Growth | -5.8% |
| Promoter Holding | 89.25% |
| 52-Week Range | ₹15.5 — ₹31.7 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹6.62 |
Strengths
- High promoter holding of 89.25% aligns management interests with minority shareholders
- Low debt-to-equity of 0.33 provides balance sheet cushion
- Sales growth of 9.76% shows some top-line expansion
- Piotroski F-Score of 6/9 suggests pockets of fundamental improvement
Concerns
- Negative ROE (-0.38%) and ROCE (-6.83%) indicate capital is not earning its keep
- Latest quarter net loss of ₹9 Cr on ₹75 Cr sales shows no current profitability
- Valuation is stretched with P/E of 98.46, P/B of 8.30, and zero dividend yield
- FairStock Score of 3/100 flags high risk; PEG of 4.12 makes growth expectations expensive
AI Analysis
Let's look at Andrew Yule. At ₹22.83, the market capitalizes this at ₹1,009 crore. That is a rich price for a business that lost ₹9 crore on sales of ₹75 crore in the latest quarter. Return on equity is -0.38% and return on capital employed is -6.83% – by any measure, this is a value-destroying operation today. The price-to-book of 8.30 times against a book value of just ₹2.75 means you are paying a massive premium for assets that are barely earning. The P/E of 98.46 is meaningless when profits are near zero, and the PEG ratio of 4.12 confirms that any growth is more than priced in. There is no dividend to compensate you while you wait. Yes, debt-to-equity is low at 0.33, and promoter holding is very high at 89.25%, which aligns interests with minority shareholders. Sales grew 9.76% and the Piotroski score of 6 suggests some operational improvements. But a tea company with negative returns and a loss-making quarter is at the mercy of commodity cycles. I prefer a fair price for a wonderful business; this is a cyclical turnaround with no demonstrated moat. The latest quarter's loss is a cold reminder that this is not a compounder. You are paying for a recovery that has not yet arrived. The 52-week range – ₹15.50 to ₹31.39 – shows how speculative this can be. For a retail investor, this is a risky bet, not an investment. I would keep it on a watchlist, not in the portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer